The peptidic CXCR4 antagonist, BL-8040, significantly reduces bone marrow immature leukemia progenitors by inducing differentiation, apoptosis and mobilization: Results of the dose escalation clinical trial in acute myeloid leukemia Meeting Abstract
| Authors: | Borthakur, G.; Ofran, Y.; Nagler, A.; Rowe, J. M.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Altman, J. K.; Frankfurt, O.; Tallman, M. S.; Peled, A.; Pereg, Y.; Vainstein, A.; Aharon, A.; Al Rawi, A.; McQueen, T.; Pemmaraju, N.; Bueso-Ramos, C. E.; Cortes, J. E.; Andreeff, M. |
| Abstract Title: | The peptidic CXCR4 antagonist, BL-8040, significantly reduces bone marrow immature leukemia progenitors by inducing differentiation, apoptosis and mobilization: Results of the dose escalation clinical trial in acute myeloid leukemia |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368020102058 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.2546.2546 |
| Notes: | Meeting Abstract: 2546 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
